ClinicalTrials.gg
Drug

Nipocalimab clinical trials

Also written JNJ-80202135 and M281.

studies test it
24
open now
9
in phase 3
10
first study started
2016

How each study uses nipocalimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the nipocalimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Apr 2025 · IMAAVY · BLA 761430 (FDA, Drugs@FDA)
European Union
28 Nov 2025 · Imaavy · EMEA/H/C/006379 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nipocalimab
19
JNJ-80202135, M281
2

Development codes

JNJ-80202135
14
M281
13
JNJ-86507083
5

Studies by the year they started

24 studies that test it; most in 2021 (6)

Studies that test nipocalimab, by start year
YearStudies
20161
20181
20193
20216
20224
20232
20242
20251
20264

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
12
Phase 3
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 0

Janssen Research & Development, LLC (21) · Momenta Pharmaceuticals, Inc. (3)

Often tested with

Tested in the same studies.

Etanercept (1) · Hydroxychloroquine (1) · Immunoglobulins, Intravenous (1) · Immunoglobulin G (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 5 in phase 3

Studies that test nipocalimab, phase 3 first.

Studies

Open first, then newest update. How each study uses nipocalimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 24

See all 24 studies that test nipocalimab →

Given beside what is tested · 1 — nipocalimab is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call nipocalimab · ClinicalTrials.gg INT002146

  • MeSH (NLM) C000731839nipocalimabOne source NLM
  • UNII (FDA) 87M90CV8NCNIPOCALIMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q130302151nipocalimabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C170891NipocalimabOne source FDA
  • DrugBank DB16257One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.